ESLA - Estrella Immunopharma, Inc. News

Discover

ESLA

Estrella Immunopharma, Inc.

0.64

1 x 0.75

1 x 0.32

bid

ask

0.09

12.27%

1 @ 04:00 PM

0.64 +0.00 (0.00%)

Ytd	-59.02%
1y	-74.93%

0.63

day range

0.79

0.24

52 week range

3.15

Open	0.72	Prev Close	0.73	Low	0.63	High	0.79	Mkt Cap	27.81M
Vol	165.56K	Avg Vol	1.78M	EPS	-0.25	P/E	N/A	Forward P/E	N/A
Beta	0.24	Short Ratio	0.07	Inst. Own	0.55%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	N/A	50-d Avg	0.58	200-d Avg	0.99	1yr Est	0.00

ESLA News

benzinga.com

Estrella Immunopharma Appoints Cynthia Pussinen CEO, Chairperson, Effective Oct. 25, Succeeding Chen

Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical

businesswire.com

Estrella Immunopharma Appoints Cynthia Pussinen as Chief Executive Officer and Chairperson of the Bo

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “

benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 58.8% to $6.65 during Friday&#39

benzinga.com

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 41.9% to $0.46 during Thursday's

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Profusa (NASDAQ:PFSA) shares moved upwards by 35.4% to $1.15 during Thursday's regular

benzinga.com

Estrella Immunopharma (ESLA) Stock Soars 18%: What’s Driving the Surge

Estrella Immunopharma shares climbed 17.91% after hours following an update on its EB103 cancer ther

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Pomdoctor (NASDAQ:POM) stock moved upwards by 115.1% to $1.43 during Wednesday's regula

benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Silence Therapeutics (NASDAQ:SLN) stock increased by 125.6% to $19.59 during Monday's r

benzinga.com

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Disc Medicine (NASDAQ:IRON) stock moved upwards by 50.4% to $85.51 during Monday's pre-

businesswire.com

Estrella Immunopharma Treats First Patient with Two EB103 Infusions in STARLIGHT-1 Dose-Expansion Ph

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “

businesswire.com

Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (“Estrella” o

benzinga.com

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Mobile-health Network (NASDAQ:MNDR) shares increased by 141.2% to $2.05 during Monday's

benzinga.com

Why J-Star Holding Shares Are Trading Higher By Around 128%; Here Are 20 Stocks Moving Premarket

J-Star Holding surged 127.9% premarket after funding U.S. drone-frame expansion; Linkers and VCI gai

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 7.8% to $1.52 during Friday's

benzinga.com

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Humana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market ses

defenseworld.net

Estrella Immunopharma (NASDAQ:ESLA) Trading Up 1.1% – Should You Buy?

Shares of Estrella Immunopharma, Inc. (NASDAQ: ESLA - Get Free Report) shot up 1.1% during trading o

businesswire.com

Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Sit

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “

benzinga.com

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday&#

benzinga.com

Estrella Immunopharma Activates Third Clinical Site For Ongoing STARLIGHT-1 Phase I/II Clinical Tria

Estrella Immunopharma, Inc. (NASDAQ:ESLA) ("Estrella" or the "Company"), a clinical-

businesswire.com

Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “

benzinga.com

Estrella Immunopharma Activates Second Clinical Facility For Its Current STARLIGHT-1 Phase I/II Clin

Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical

businesswire.com

Estrella Immunopharma Activates Baylor Scott & White Research Institute as Second Clinical Site for

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “

benzinga.com

Estrella Immunopharma Doses First Participant In Its Current STARLIGHT-1 Phase I/II Clinical Study O

Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical

businesswire.com

Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “

benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's

benzinga.com

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday&#

benzinga.com

Estrella Immunopharma Q1 EPS $(0.05) Beats $(0.18) Estimate

Estrella Immunopharma (NASDAQ:ESLA) reported quarterly losses of $(0.05) per share which beat the an

businesswire.com

Estrella Immunopharma to Participate in the D. Boral Capital Global Conference

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (“Estrella” o

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session

businesswire.com

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/S

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (“Estrella” o

benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com

D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy a

benzinga.com

12 Health Care Stocks Moving In Monday's Pre-Market Session

businesswire.com

Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tand

EMERYVILLE, Calif.--(BUSINESS WIRE)-- #2026TandemMeetings--Estrella Immunopharma, Inc. (Nasdaq: ESLA

benzinga.com

Why STMicroelectronics Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session

businesswire.com

Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB10

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (Nasdaq: ESLA) (“Estrella” or the “

benzinga.com

D. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy a

businesswire.com

Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Pr

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (the “Company

businesswire.com

Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (the “Company”), a c

benzinga.com

Estrella Immunopharma Offers Up To 2,541,206 Shares For Resale By The Selling Stockholders

ESTRELLA IMMUNOPHARMA, INC.Up to 2,541,206 Shares of Common StockThis prospectus relates to the offe

defenseworld.net

Estrella Immunopharma (NASDAQ:ESLA) & Foghorn Therapeutics (NASDAQ:FHTX) Head-To-Head Contrast

Foghorn Therapeutics (NASDAQ: FHTX - Get Free Report) and Estrella Immunopharma (NASDAQ: ESLA - Get

benzinga.com

Estrella Immunopharma Recommended By Independent Data Safety Monitoring Board To Advance STARLIGHT-1

Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical

businesswire.com

Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session